Bio Green Med Solution, Inc. (BGMS)

Bio Green Med Solution Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2024	FY 2024	FY 2024	FY 2023
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Mar 31, 2024	Dec 31, 2023	Dec 31, 2022
Revenue	-0.34	-	0.04	-	0.42	-
Cost of Revenue	-	-1.5	-	-1.64	-	-
Gross Profit	-0.34	1.5	0.04	1.64	0.42	-
Selling, General & Admin	7.25	-0.59	5.39	-0.69	6.72	7.38
Research & Development	-7.14	-	6.66	-	19.16	20.27
Total Operating Expenses	0.11	-0.59	12.05	-0.69	25.87	27.66
Operating Income	-0.44	2.09	-12	2.33	-25.45	-27.66
Interest Income	-	0.07	-	0.06	-	0.21
Interest Expense	-	0	-0.01	0.01	-0.27	-
Other Non-Operating Income (Expense)	-0.01	-	-0.12	-	-0.37	1.53
Total Non-Operating Income (Expense)	-0.01	0.07	-0.13	0.07	-0.63	1.74
Pretax Income	-0.45	2.16	-12.13	2.4	-26.09	-25.92
Provision for Income Taxes	1.58	-0.01	-0.78	0.04	-3	-4.72
Net Income	2.85	2.17	-11.21	2.36	-22.76	-21.4
Net Income Attributable to Preferred Dividends	-0.13	-	-	-	0.2	0.2
Net Income to Common	2.85	2.17	-11.21	2.36	-22.76	-21.4
Shares Outstanding (Basic)	-	3	-	3	0	0
Shares Outstanding (Diluted)	-	3	-	3	0	0
Shares Change (YoY)	-	-	-	84524.74%	13.38%	26.10%
EPS (Basic)	-	-0.03	-	-0.06	-6420.00	-6888.00
EPS (Diluted)	-	-0.03	-	-0.06	-6420.00	-6888.00
Free Cash Flow	0	0.39	-7.99	60.26	-16.12	-20.83
Free Cash Flow Per Share	-	0.13	-	20.09	-4546.61	-6663.51
Gross Margin	100.00%	-	100.00%	-	100.00%	-
Operating Margin	131.25%	-	-27916.28%	-	-6060.24%	-
Profit Margin	604.17%	-	-26395.35%	-	-5497.38%	-
FCF Margin	0.00%	-	-18581.40%	-	-3837.62%	-
EBITDA	-0.44	2.09	-12	2.35	-25.42	-27.62
EBITDA Margin	131.25%	-	-27902.33%	-	-6052.86%	-
EBIT	-0.44	2.09	-12	2.33	-25.45	-27.66
EBIT Margin	131.25%	-	-27916.28%	-	-6060.24%	-
Effective Tax Rate	-355.16%	-0.51%	6.45%	1.59%	11.49%	18.20%

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.